###begin article-title 0
###xml 68 73 <span type="species:ncbi:10090">Mouse</span>
Assessing Tumor Progression Factors by Somatic Gene Transfer into a Mouse Model: Bcl-xL Promotes Islet Tumor Cell Invasion
###end article-title 0
###begin p 1
###xml 532 541 532 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(RIP-Tag)</italic>
###xml 595 605 595 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(RIP-tva),</italic>
###xml 704 711 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 718 734 718 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1078 1094 1066 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1688 1704 1676 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1769 1775 1757 1763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 460 463 <span type="species:ncbi:10116">rat</span>
###xml 517 521 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 574 594 <span type="species:ncbi:11864">avian leukosis virus</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 888 893 <span type="species:ncbi:9606">human</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
Tumors develop through multiple stages, implicating multiple effectors, but the tools to assess how candidate genes contribute to stepwise tumor progression have been limited. We have developed a novel system in which progression of phenotypes in a mouse model of pancreatic islet cell tumorigenesis can be used to measure the effects of genes introduced by cell-type-specific infection with retroviral vectors. In this system, bitransgenic mice, in which the rat insulin promoter (RIP) drives expression of both the SV40 T antigen (RIP-Tag) and the receptor for subgroup A avian leukosis virus (RIP-tva), are infected with avian viral vectors carrying cDNAs encoding candidate progression factors. Like RIP-Tag mice, RIP-Tag; RIP-tva bitransgenic mice develop isolated carcinomas by approximately14 wk of age, after progression through well-defined stages that are similar to aspects of human tumor progression, including hyperplasia, angiogenesis, adenoma, and invasive carcinoma. When avian retroviral vectors carrying a green fluorescent protein marker were introduced into RIP-Tag; RIP-tva mice by intra-cardiac injection at the hyperplastic or early dysplastic stage of tumorigenesis, approximately 20% of the TVA-positive cells were infected and expressed green fluorescent proteins as measured by flow cytometry. Similar infection with vectors carrying cDNA encoding either of two progression factors, a dominant-negative version of cadherin 1 (dnE-cad) or Bcl-xL, accelerated the formation of islet tumors with invasive properties and pancreatic lymph node metastasis. To begin studying the mechanism by which Bcl-xL, an anti-apoptotic protein, promotes invasion and metastasis, RIP-Tag; RIP-tva pancreatic islet tumor cells were infected in vitro with RCASBP-Bcl-xL. Although no changes were observed in rates of proliferation or apoptosis, Bcl-xL altered cell morphology, remodeled the actin cytoskeleton, and down-regulated cadherin 1; it also induced cell migration and invasion, as evaluated using two-chamber transwell assays. In addition, myosin Va was identified as a novel Bcl-xL-interacting protein that might mediate the effects of Bcl-xL on tumor cell migration and invasion.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Cancer cells accumulate multiple genetic alterations. Some of these contribute to tumor development while others are a mere by-product of genomic instability. To determine whether a candidate gene can promote tumor development, we have developed a novel experimental system using engineered viruses to deliver genes into premalignant lesions. We used genetically engineered mice in which both an oncogene (SV40 T antigen) and a specific docking molecule for the virus are produced in beta cells in the pancreatic islets of Langerhans. Tumors form in only a subset of the islets expressing this oncogene, indicating that tumor development requires other events. Since these precancerous cells also express the virus docking molecule, we could deliver candidate progression genes via the virus to see whether they contributed to tumor progression. We show that genes encoding two proteins (a survival factor, Bcl-xL, and an inhibitory form of the cell adhesion molecule cadherin 1) can be delivered into premalignant beta cells and thereby enhance tumorigenesis. Both of these proteins were previously implicated in tumor progression, confirming that our technique can identify such progression genes. Moreover, we find that Bcl-xL promotes tumor cell migration and invasion by a mechanism distinct from its known role in cell survival.
###end p 4
###begin p 5
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
A new technique using lentivirus to deliver genes into targeted cell types reveals that the tumor progression geneBcl-xL not only promotes cell survival in premalignant cells but also promotes tumor cell invasion.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b001">1</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b002">2</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b003">3</xref>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b004">4</xref>
Cancer typically arises by a multi-step process during which cells acquire activating mutations in oncogenes and inactivating mutations in tumor suppressor genes [1]. By comparing cancer tissues with their normal counterparts, it is possible to identify many differences in cellular, molecular, and biological properties. For example, transcriptional profiling and genome sequencing methods have documented alterations in gene expression and somatic mutations in cancers [2,3]. Several types of cancers share common somatic changes or display changes in the same functional pathways, revealing the underlying principles that drive the transformation of normal cells into highly malignant derivatives [4].
###end p 7
###begin p 8
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b005">5</xref>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b006">6</xref>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b007">7</xref>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b008">8</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 579 584 <span type="species:ncbi:10090">mouse</span>
Mouse models of human cancers provide important experimental systems for understanding the complexities of human cancer pathogenesis [5,6]. However, in most mouse models, mutant genes have been more clearly implicated in the initiation than in the progression of cancer, even when newer methods, such as Cre/loxP-mediated recombination or tetracycline- or estrogen-based gene regulation, are used to produce a particular gene product conditionally in a tissue-specific and time-controlled manner [7,8]. Moreover, it is time-consuming and expensive to generate alterations in the mouse germ line for each gene of interest.
###end p 8
###begin p 9
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b009">9</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b010">10</xref>
###xml 422 431 422 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 436 443 436 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b011">11</xref>
###xml 1408 1410 1390 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b012">12</xref>
###xml 295 315 <span type="species:ncbi:11864">avian leukosis virus</span>
###xml 456 461 <span type="species:ncbi:10090">mouse</span>
###xml 588 592 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 641 644 <span type="species:ncbi:10116">Rat</span>
###xml 825 840 <span type="species:ncbi:10090">transgenic mice</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
Seeking to improve means for studying later stages in tumorigenesis, we have developed a strategy for assessing causal links between individual genes and specific cellular changes during tumor progression. The strategy is based on the use of a transgene that encodes the receptor for subgroup A avian leukosis virus, TVA, allowing cell-specific infection with avian retroviral vectors during tumor development [9,10]. The RIP1-Tag2 (or RIP-Tag) transgenic mouse [11] was chosen as a platform to study the effects of candidate genes in tumor progression. In this well-characterized model, SV40 T antigen is expressed under the control of the Rat insulin promoter (RIP) in the beta cells of pancreatic islets, providing the driving force for tumor initiation by blocking the activities of the Rb and p53 tumor suppressors. The transgenic mice develop multifocal pancreatic beta-cell tumors through well-defined stages that resemble lesions of human tumor development and progression. The natural focal distribution of the target tissue, into approximately400 focal nodules, has facilitated identification and quantification of the distinguishable stages in islet tumorigenesis, which include hyperplasia or low-grade dysplasias ("hyperplastic islets"), high-grade angiogenic dysplasias ("angiogenic islets"), encapsulated, noninvasive islet tumors (IT, adenomas), and distinctive grades of invasive carcinoma [12].
###end p 9
###begin p 10
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 200 216 194 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 401 404 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 412 414 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b013">13</xref>
###xml 415 417 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b014">14</xref>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 339 359 <span type="species:ncbi:11864">avian leukosis virus</span>
###xml 397 400 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
Using a RIP-tva transgene to express the TVA receptor in beta cells of the pancreas, we demonstrate that candidate genes can be introduced somatically into developing neoplastic beta- cell lesions in RIP-Tag; RIP-tva bitransgenic mice by infection with a subgroup A avian retroviral vector, termed RCASBP (subgroup A replication-competent avian leukosis virus with a splice acceptor and the Bryan-RSV pol gene) [13,14], thereby modulating tumorigenesis. By doing so, we have established the functional roles of two candidate progression factors, a dominant-negative form of cadherin 1 (dnE-cad) and Bcl-xL, when introduced stochastically in incipient neoplasias. Our study also reveals an unexpected activity of Bcl-xL in altering the actin cytoskeleton and promoting invasiveness, findings substantiated by analysis of cultured tumor cells. Our results suggest that targeted somatic delivery of candidate progression factors via retrovirus vectors will be useful for identifying factors and dissecting mechanisms that underlie advanced stages of tumorigenesis.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 54 58 <span type="species:ncbi:10090">Mice</span>
Generation and Characterization of RIP-tva Transgenic Mice
###end title 12
###begin p 13
###xml 159 160 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b009">9</xref>
###xml 161 163 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b010">10</xref>
###xml 222 224 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b015">15</xref>
###xml 394 402 388 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g001">Figure 1</xref>
###xml 404 405 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g001">1</xref>
###xml 436 443 430 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 135 157 <span type="species:ncbi:11864">avian leukosis viruses</span>
###xml 280 295 <span type="species:ncbi:10090">transgenic mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
The general strategy employed in this work involves equipping pancreatic beta cells with TVA, the cell surface receptor for subgroup A avian leukosis viruses [9,10], so that the cells are susceptible to the RCASBP vector [15] derived from those viruses. To that end, we generated transgenic mice that express TVA under the control of the RIP exclusively in the beta cells of pancreatic islets (Figure 1A-1C). Three independent lines of RIP-tva mice transmitted the transgene in a simple Mendelian pattern of inheritance.
###end p 13
###begin title 14
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Characterization of RIP-tva Transgenic Mice
###end title 14
###begin p 15
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tva</italic>
###xml 216 237 216 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 139 142 <span type="species:ncbi:10116">rat</span>
(A) The RIP-tva transgene. The 800-bp tva cDNA was cloned into a XbaI/HindIII-digested plasmid that contains the 5' flanking region of the rat insulin II gene and transcription termination sequences (An) (details in Materials and Methods).
###end p 15
###begin p 16
###xml 163 170 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
(B and C) Confocal microscopic images show immunofluorescent membrane staining of TVA (red) and nuclear staining of PDX1 (green) in pancreatic sections of 2-d-old RIP-tva transgenic (B) and non-transgenic (C) animals. Nuclei were stained with DAPI (blue). Original magnification, 630x. The images are representative of 20 fields from 12 mice analyzed.
###end p 16
###begin p 17
###xml 149 165 149 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
(D) Confocal microscopic immunofluorescent image of hyperplastic islet cells revealed TVA (red) and PDX1 (green) in pancreatic section of a 7-wk-old RIP-Tag; RIP-tva bitransgenic animal. The image is representative of 15 fields from three mice analyzed.
###end p 17
###begin p 18
###xml 54 58 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
(E) The adjacent section of (D) was immunostained for SV40 T antigen. The image is representative of 15 fields from three mice analyzed.
###end p 18
###begin p 19
Ex, exocrine tissue.
###end p 19
###begin p 20
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 459 466 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 516 524 513 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g001">Figure 1</xref>
###xml 610 617 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 624 632 621 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g001">Figure 1</xref>
###xml 678 686 675 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g001">Figure 1</xref>
###xml 881 888 875 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 131 137 <span type="species:ncbi:9986">rabbit</span>
###xml 254 258 <span type="species:ncbi:9925">goat</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 889 904 <span type="species:ncbi:10090">transgenic mice</span>
To detect TVA on the surface of pancreatic cells in RIP-tva newborn and adult mice, we performed immunofluorescent staining with a rabbit polyclonal anti-TVA antibody on pancreatic sections. To identify pancreatic islets, we co-stained the sections with goat antisera against PDX1, a transcription factor expressed in pancreatic precursor cells and islet beta cells. In both newborn and adult animals, TVA was observed in cells within the islets in all three RIP-tva transgenic lines with similar expression levels (Figure 1B and data not shown). No TVA staining was detected in either exocrine cells from the RIP-tva mice (Figure 1B) or pancreases from non-transgenic animals (Figure 1C). In addition, expression of TVA in other organs was not detected by immunofluorescent staining (data not shown). We conclude that TVA is produced specifically in the pancreatic beta islets of RIP-tva transgenic mice, although we cannot rule out the possibility that other cell types may express the transgene at levels below those detectable with the method employed.
###end p 20
###begin p 21
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
Examination of pancreatic tissues from newborn and adult animals did not reveal any significant differences in islet morphology between RIP-tva animals and non-transgenic littermates (data not shown). The distribution and presence of cells expressing insulin II (known as insulin), glucagon, somatostatin, and pancreatic polypeptide were also similar in RIP-tva mice and non-transgenic littermates (data not shown), indicating that the viral receptor, TVA, itself did not perturb any of the properties of islet cells that might be relevant to this study.
###end p 21
###begin title 22
###xml 17 33 17 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
Gene Transfer to RIP-Tag; RIP-tva Cells In Vitro and In Vivo
###end title 22
###begin p 23
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 223 239 223 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g002">Figure 2</xref>
###xml 335 342 335 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b016">16</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b017">17</xref>
###xml 458 465 458 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 559 566 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
To prepare to study the effects of candidate progression factors, introduced by virus infection, on the course of tumor development, one of the three RIP-tva lines was crossed with the RIP-Tag line to generate bitransgenic RIP-Tag; RIP-tva mice (Figure 2A). It has been shown that the strain backgrounds influence the tumorigenesis of RIP-Tag mice, and the course of tumorigenesis is more consistent in a C57BL/6 background [16,17]. We therefore backcrossed RIP-tva mice from a mixed genetic background for ten generations onto a pure C57BL/6 background with RIP-Tag.
###end p 23
###begin title 24
###xml 13 29 13 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
Infection of RIP-Tag; RIP-tva Pancreatic Islet Cells In Vitro and In Vivo
###end title 24
###begin p 25
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 105 121 105 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
###xml 77 92 <span type="species:ncbi:10090">transgenic mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
(A) Experimental strategy. RIP-Tag transgenic mice were crossed with RIP-tva transgenic mice to generate RIP-Tag; RIP-tva bitransgenic mice. For in vitro experiments, tumors from 16-wk-old bitransgenic mice were isolated and cultured in vitro, and tumor cells were infected with RCASBP viruses (left). For in vivo infection, RCASBP viruses were delivered into 7-wk-old bitransgenic animals through intra-cardiac (I.C.) injection. Characterization of islet cells/tumors was performed 2, 5, or 9 wk after viral delivery (right).
###end p 25
###begin p 26
###xml 85 101 85 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
(B and C) Example of infection in vitro with an RCASBP vector. Bright-field image of RIP-Tag; RIP-tva tumor cells infected with RCASBP-GFP in vitro (B) and fluorescent image showing GFP expression (C) were taken 1 wk after infection. The images are representative of more than 20 fields from two independent infections.
###end p 26
###begin p 27
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 179 195 179 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 643 650 643 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 654 670 654 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 712 713 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 753 754 753 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 807 811 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 129 134 <span type="species:ncbi:10090">mouse</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
(D) Flow cytometry plots of islet cells from wide-type mouse (C57BL/6) injected with RCASBP-GFP (upper left), RIP-tva transgenic mouse injected with RCASBP-GFP (upper right), and RIP-Tag; RIP-tva bitransgenic mice injected with RCASBP-ALPP (lower left) or RCASBP-GFP (lower right) via intra-cardiac injection. RCASBP viral supernatants were delivered at the age of 7 wk. Two weeks later, mice were sacrificed, and pancreases were digested into single-cell suspension. Cells were analyzed for TVA+ and GFP by FACS. The percentage of cells in each gated panel is indicated in the corners. Approximately 11%-18% of pancreatic cells isolated from RIP-tva or RIP-Tag; RIP-tva bitransgenic mice by this method were TVA+ (upper quadrants), and about 20% of TVA+ cells from bitransgenic animals infected with RCASBP-GFP expressed GFP.
###end p 27
###begin p 28
###xml 111 119 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g001">Figure 1</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g001">1</xref>
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b018">18</xref>
###xml 525 541 522 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 675 679 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 935 943 929 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g002">Figure 2</xref>
###xml 949 950 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g002">2</xref>
###xml 51 55 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
We initially verified the co-production of TVA and SV40 T antigen in the islets of 7-wk-old bitransgenic mice (Figure 1D and 1E). We then determined whether the RIP-tva transgene conferred susceptibility to infection by RCASBP viruses in islet cells derived from the bitransgenic mice. Cell proliferation is required for successful infection by RCASBP retroviruses, but adult islet cells have low proliferation rates [18]. To increase the fraction of proliferating cells, cultures were established from beta-cell tumors from RIP-Tag; RIP-tva bitransgenic mice, and the tumor cells were infected with a RCASBP vector carrying the green fluorescent protein (GFP) marker (RCASBP-GFP). Analysis by fluorescence microscopy at 1 wk after the second of two rounds of infection revealed that more than 70% of the tumor cells expressed GFP, demonstrating that cells derived from the beta-cell tumors were readily infectable by RCASBP in vitro (Figure 2B and 2C). No green fluorescence was detectable in uninfected cells (data not shown).
###end p 28
###begin p 29
###xml 60 76 60 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g002">Figure 2</xref>
###xml 630 651 630 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b019">19</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b020">20</xref>
###xml 893 901 893 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g002">Figure 2</xref>
###xml 1146 1153 1146 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 1197 1201 1197 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 1311 1316 1311 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALPP;</italic>
###xml 1343 1346 1343 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-AP</italic>
###xml 1349 1357 1349 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g002">Figure 2</xref>
###xml 1403 1410 1403 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 1454 1458 1454 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 1223 1227 <span type="species:ncbi:10090">mice</span>
###xml 1266 1271 <span type="species:ncbi:9606">human</span>
We next evaluated gene transfer in vivo. We chose to infect RIP-Tag; RIP-tva bitransgenic animals at 7 wk after birth, an age when hyperplastic islets develop in RIP-Tag mice. A concentrated preparation of RCASBP-GFP viruses (0.1 ml; >108 infectious units per milliliter) was delivered by intra-cardiac injection to ensure distribution of viruses to all organs fed by the arterial circulation. Two weeks after infection, the percentage of GFP-expressing TVA-positive cells in the islets was determined by fluorescence-activated cell sorting (FACS) (Figure 2D). Suspensions of single pancreatic cells were prepared as described in Materials and Methods, using a protocol modified from Shih et al. [19] and Dor et al. [20]. Approximately 11%-18% of the cells in these preparations were TVA-positive when isolated from bitransgenic animals, and about 20% of the TVA-positive cells expressed GFP (Figure 2D, lower right panel), implying that the infection efficiency in vivo is around 20% in TVA-positive cells. The green fluorescence was not due to autofluorescence, because almost no fluorescence was observed in pancreatic cells from wild-type or RIP-tva monotransgenic animals injected with RCASBP-GFP or from bitransgenic mice injected with RCASBP viruses encoding human placental alkaline phosphatase (RCASBP-ALPP; previously known as RCASBP-AP) (Figure 2D). The lack of detectable infection in adult RIP-tva monotransgenic animals injected with RCASBP-GFP confirmed that proliferation of the TVA-expressing cells is necessary for successful infection.
###end p 29
###begin title 30
###xml 51 67 51 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 68 72 <span type="species:ncbi:10090">Mice</span>
dnE-cad Promotes Invasive Tumors and Metastasis in RIP-Tag; RIP-tva Mice
###end title 30
###begin p 31
###xml 166 173 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 192 208 189 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 366 368 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b021">21</xref>
###xml 401 424 398 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2; RIP1-dnE-cad</italic>
###xml 498 505 495 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dnE-cad</italic>
###xml 676 678 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b022">22</xref>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
To ascertain whether the development of beta-cell tumours could be accelerated by the somatic delivery of factors previously reported to promote tumor progression in RIP-Tag mice, we infected RIP-Tag; RIP-tva bitransgenic mice with RCASBP vectors that carry cDNA encoding dnE-cad, a mutant protein lacking the extracellular, adhesion-mediating domain of cadherin 1 [21]. In previous studies involving RIP1-Tag2; RIP1-dnE-cad bitransgenic mice, suppression of cadherin 1 function by expression of a dnE-cad cDNA enhanced and accelerated the progression from noninvasive ITs (adenomas) to invasive carcinomas and increased the frequency of otherwise rare lymph node metastasis [22].
###end p 31
###begin p 32
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 132 148 132 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 198 206 198 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g003">Figure 3</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b023">23</xref>
###xml 440 448 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g003">Figure 3</xref>
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g003">Figure 3</xref>
###xml 616 624 616 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g003">Figure 3</xref>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
We injected high titer stocks (>108 infectious units per milliliter) of RCASBP viruses carrying cDNA encoding dnE-cad into 7-wk-old RIP-Tag; RIP-tva bitransgenic animals by the intra-cardiac route (Figure 3A). Nine weeks later, pancreases from 16-wk-old mice were harvested for histological staging and grading of the lesions according to established criteria [23]. In brief, tumors were scored as IT (noninvasive tumor; >1 mm in diameter; Figure 3B); invasive carcinoma type 1 (IC-1; >1 mm in diameter; focal regions of invasion; Figure 3C); or invasive carcinoma type 2 (IC-2; variable sizes; widespread invasion; Figure 3D). Pancreatic sections were also subjected to immunohistochemical tests for the expression of synaptophysin, a neuroendocrine marker found in all types of islet cells, and for insulin II, a beta-cell marker.
###end p 32
###begin title 33
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
RIP-Tag; RIP-tva Islet Tumorigenesis and Examples of Histological Categories
###end title 33
###begin p 34
###xml 36 52 36 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 92 101 92 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 415 422 415 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050276-t001">Table 1</xref>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">Mice</span>
(A) Schematic representation of the RIP-Tag; RIP-tva islet tumorigenesis (modified from the RIP1-Tag2 Manual, Hanahan laboratory, unpublished). RCASBP retroviruses carrying genes of interest were introduced into the hyperplastic islets of 7-wk-old mice through intra-cardiac injection. Mice were sacrificed at 16 wk of age for histological staging and grading to determine tumor incidence and phenotype as shown in Table 1.
###end p 34
###begin p 35
(B-D) Hematoxylin and eosin stain of representative examples of IT (B), IC-1 (C), and IC-2 (D).
###end p 35
###begin p 36
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
Impact of RCAS-Bcl-xL and RCAS-dnE-cad on Tumorigenesis In Vivo
###end p 36
###begin p 37
###xml 48 55 48 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050276-t001">Table 1</xref>
###xml 145 153 145 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 299 307 299 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 457 465 457 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 518 521 518 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 747 755 744 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 808 815 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050276-t001">Table 1</xref>
###xml 817 825 814 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g004">Figure 4</xref>
###xml 889 896 886 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 924 940 921 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 979 984 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 1113 1121 1110 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 1131 1137 1128 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP,</italic>
###xml 1170 1193 1167 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2; RIP1-dnE-cad</italic>
###xml 1258 1274 1255 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1399 1407 1396 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dnE-cad,</italic>
###xml 1598 1600 1595 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b022">22</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
###xml 1275 1279 <span type="species:ncbi:10090">mice</span>
By counting and classifying pancreatic lesions (Table 1), we found that (i) the average tumor incidence in bitransgenic mice infected with RCASBP-dnE-cad (n = 11) was 1.5-fold higher than that in bitransgenic mice injected with the control RCASBP-ALPP viruses (n = 6); (ii) mice injected with RCASBP-dnE-cad (n = 11) exhibited a higher incidence of invasive carcinomas than mice injected with the control viruses (n = 6); and (iii) mice injected with RCASBP-dnE-cad had a higher tumor burden than controls (p = 0.003, n = 6 for each group, Wilcoxon rank sum test). By staining pancreatic lymph nodes with antisera against insulin II and synaptophysin to search for metastatic beta-cell tumors, we found that six of the 15 mice infected with RCASBP-dnE-cad developed metastases to the pancreatic lymph nodes (Table 1; Figure 4A, upper panel); metastases were not detected in monotransgenic RIP-Tag mice of the same age or in RIP-Tag; RIP-tva bitransgenic mice infected with RCASBP-ALPP. No metastases to other distant organs (liver, kidney, lung, heart, or thymus) were observed in the animals infected with RCASBP-dnE-cad or RCASBP-ALPP, consistent with the findings in RIP1-Tag2; RIP1-dnE-cad bitransgenic mice. Taken together, these data indicate that the RIP-Tag; RIP-tva mice can be used to assess the effects of genes of interest on tumor progression in vivo, with targeted somatic delivery of dnE-cad, largely recapitulating the effects seen with a traditional transgenic approach that constitutively expresses the candidate progression factor in all of the target cells throughout ontogeny [22].
###end p 37
###begin title 38
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 82 86 <span type="species:ncbi:10090">Mice</span>
Detection of Metastasis and Assessment of the Differentiation Status of IC-2 from Mice Infected with RCASBP-Bcl-xL and RCASBP-dnE-cad
###end title 38
###begin p 39
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
(A) Representative images of lymph node metastases found in six mice infected with RCASBP-dnE-cad (upper panel) or in seven mice infected with RCASBP-Bcl-xL (lower panel). Immunohistochemical staining of insulin II in metastatic beta-cell tumor cells in pancreatic lymph nodes is shown. Original magnification, 200x.
###end p 39
###begin p 40
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 290 298 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 322 329 319 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
(B) About 4.5% of IC-2 found in mice infected with RCASBP-dnE-cad or RCASBP-Bcl-xL do not express insulin II. Immunohistochemical staining of synaptophysin, a neuroendocrine marker (left), and insulin II (right) in beta-cell tumor cells in pancreatic sections from mice injected with RCASBP-dnE-cad (upper panel) or RCASBP-Bcl-xL (lower panel). Original magnification, 200x (upper panel) and 100x (lower panel).
###end p 40
###begin title 41
###xml 50 66 50 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 67 71 <span type="species:ncbi:10090">Mice</span>
Bcl-xL Increases Tumor Invasion and Metastasis in RIP-Tag; RIP-tva Mice
###end title 41
###begin p 42
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b024">24</xref>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 234 245 234 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP7-Bcl-xL</italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b025">25</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b026">26</xref>
###xml 486 492 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 653 675 653 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2; RIP7-Bcl-xL</italic>
###xml 350 355 <span type="species:ncbi:10090">mouse</span>
###xml 383 387 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
We next investigated a second progression factor, Bcl-xL, a member of the anti-apoptotic subgroup of the BCL2 family of apoptotic regulators [24] via somatic gene transfer. In previous studies, constitutive expression of Bcl-xL via a RIP7-Bcl-xL transgene was found to suppress apoptosis and alternatively accelerate or enable islet tumorigenesis in mouse models of cancer evoked by SV40 T antigen [25] or MYC [26], respectively. We sought to assess the effects of expressing exogenous Bcl-xL in sporadic cells, beginning after neoplastic development had ensued, as contrasted to its constitutive expression throughout tumorigenesis in the bitransgenic RIP1-Tag2; RIP7-Bcl-xL mice.
###end p 42
###begin p 43
###xml 92 108 92 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050276-t001">Table 1</xref>
###xml 302 309 302 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 415 418 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 453 460 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 462 465 462 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 571 574 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 669 670 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 680 683 680 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 787 794 787 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 882 889 882 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050276-t001">Table 1</xref>
###xml 891 899 891 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g004">Figure 4</xref>
###xml 945 951 945 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 1136 1137 1136 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
We injected high titer stocks of RCASBP viruses carrying cDNA encoding Bcl-xL into 7-wk-old RIP-Tag; RIP-tva bitransgenic mice, and subsequently harvested pancreases at 16 wk of age for histopathology (Table 1). We observed that (i) the average tumor incidence in bitransgenic mice infected with RCASBP-Bcl-xL (n = 10) was 2-fold higher than that in bitransgenic mice injected with the control RCASBP-ALPP viruses (n = 6); (ii) mice infected with RCASBP-Bcl-xL (n = 10) exhibited a higher incidence of invasive carcinomas than did mice that received the control viruses (n = 6); and (iii) mice infected with RCASBP-Bcl-xL displayed a higher tumor burden than controls (p = 0.003, n = 6 for each group, Wilcoxon rank sum test). We also found that seven of the 15 mice infected with RCASBP-Bcl-xL developed metastases to the pancreatic lymph nodes, but no metastases to other organs (Table 1; Figure 4A, lower panel). Therefore, overexpression of Bcl-xL, beginning in hyperplastic or early dysplastic lesions, after tumorigenesis had been initiated, increased tumor burden, incidence, and invasion, and facilitated lymph node metastasis (p = 0.05, Fisher's exact test).
###end p 43
###begin p 44
###xml 140 156 128 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 182 189 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 199 207 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 209 217 197 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g004">Figure 4</xref>
###xml 321 329 309 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g004">Figure 4</xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
Histological analysis of the tumors revealed that insulin II expression was not detectable in a small subset (approximately4.5%) of IC-2 in RIP-Tag; RIP-tva mice infected with RCASBP-Bcl-xL or RCASBP-dnE-cad (Figure 4B, right panels). All tumors stained with antisera recognizing the neuroendocrine marker synaptophysin (Figure 4B, left panels), suggesting a process of de-differentiation or transformation of less mature cells into an "anaplastic" islet carcinoma, a phenotype not observed in bitransgenic animals that were uninfected or infected with control vectors.
###end p 44
###begin p 45
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b024">24</xref>
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 486 492 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP,</italic>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 517 525 517 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 745 753 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">Figure 5</xref>
###xml 1182 1204 1182 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2; RIP7-Bcl-xL</italic>
###xml 1344 1346 1341 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b025">25</xref>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 1218 1222 <span type="species:ncbi:10090">mice</span>
Bcl-xL is known to protect cells from apoptosis [24]. We therefore investigated whether the increased invasive and metastatic behavior of the tumors from mice infected with RCASBP-Bcl-xL was due to increased cell survival, producing greater cell numbers and a higher probability of tumor spread, or due to some other properties of Bcl-xL. We observed no significant differences in proliferative or apoptotic indices by staining tumors from 16-wk-old mice previously infected with RCASBP-ALPP, RCASBP-Bcl-xL, or RCASBP-dnE-cad with antisera against a proliferation marker, MKI67 (antigen identified by monoclonal antibody Ki67), or against activated caspase 3 (Kruskal-Wallis nonparametric test, three-way test, p = 0.79 and 0.69, respectively) (Figure 5A). These results suggest that the increased invasive and metastatic properties were not due to the effects of Bcl-xL on proliferation or survival of the cancer cells at the stages of adenomas and carcinomas. However, it remains possible that Bcl-xL provides some protection from apoptosis at the metastatic stage or earlier stages in tumorigenesis, as cell death is greatly reduced in both hyperplastic and angiogenic islets in RIP1-Tag2; RIP7-Bcl-xL bitransgenic mice that constitutively express high levels of Bcl-xL in all beta cells in normal islets and at all stages of tumorigenesis [25]. Since only a small fraction of the beta cells in premalignant lesions became somatically infected in our experiments, such effects would likely be masked by the preponderance of uninfected cells in those lesions.
###end p 45
###begin title 46
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 40 56 40 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 57 61 <span type="species:ncbi:10090">Mice</span>
RCASBP-Bcl-xL Enhances Tumorigenesis in RIP-Tag; RIP-tva Mice
###end title 46
###begin p 47
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
RIP-Tag; RIP-tva mice were injected with RCASBP-ALPP (control), RCASBP-Bcl-xL, or RCASBP-dnE-cad at 7 wk of age, and were sacrificed at the indicated ages for histopathological analysis.
###end p 47
###begin p 48
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 149 157 149 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 167 175 167 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
(A) Proliferative index (upper panel) and apoptotic index (lower panel) in the tumors from 16-wk-old mice injected with RCASBP-ALPP (control), RCASBP-Bcl-xL, or RCASBP-dnE-cad were determined. Pancreatic sections were stained with antibodies against Ki67 or activated caspase 3. Data shown are the mean percentage +/- standard deviation from ten tumors of each group.
###end p 48
###begin p 49
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 10 14 <span type="species:ncbi:10090">Mice</span>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
(B and C) Mice injected with RCASBP-ALPP (control) or RCASBP-Bcl-xL were sacrificed at the indicated ages to evaluate tumor burden (B, upper panel). A standard formula for tumor volume was applied (volume [mm3] = 0.52 x width2 x length). Tumor burden per mouse is the sum of the tumor volume. Pancreatic sections were stained with synaptophysin for identification of islet cells. Tumor incidence was determined (B, lower panel), and the different categories of tumors were counted (C).
###end p 49
###begin p 50
###xml 133 149 133 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 267 275 267 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">Figure 5</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">5</xref>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050276-t001">Table 1</xref>
###xml 486 502 486 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 528 535 528 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 583 584 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 753 758 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 760 768 758 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">Figure 5</xref>
###xml 866 873 864 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 907 913 905 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP;</italic>
###xml 980 996 978 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1022 1029 1020 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1040 1048 1038 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">Figure 5</xref>
###xml 1446 1448 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b023">23</xref>
###xml 1627 1634 1625 1632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1640 1656 1638 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 841 845 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1293 1297 <span type="species:ncbi:10090">mice</span>
###xml 1316 1320 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1657 1661 <span type="species:ncbi:10090">mice</span>
To determine whether the effects of Bcl-xL occurred early or late in the neoplastic process, we examined sections of pancreases from RIP-Tag; RIP-tva mice at 2 and 5 wk after RCASBP-Bcl-xL delivery (9 and 12 wk of age, respectively), as well as 9 wk after infection (Figure 5B and 5C). This experiment not only confirmed the findings presented in Table 1 at late times after infection, but also showed that the effects of Bcl-xL could be observed as early as 2 wk after viral delivery. RIP-Tag; RIP-tva mice infected with RCASBP-Bcl-xL exhibited higher tumor burdens (for three ages p </= 0.009, Wilcoxon rank sum test) and a greater tumor incidence at all three ages (9, 12, and 16 wk of age) than did the bitransgenic control mice infected with RCASBP-ALPP (Figure 5B). In addition, at all ages the numbers of IC-1 and IC-2 were higher in mice infected with RCASBP-Bcl-xL than in mice that received RCASBP-ALPP; furthermore, the small invasive carcinomas appeared before ITs in RIP-Tag; RIP-tva mice at 2 wk after RCASBP-Bcl-xL delivery (Figure 5C). These findings suggest that some of the hyperplastic or angiogenic islets develop highly invasive carcinomas (variable sizes) without progressing through a noninvasive IT stage (>1 mm in diameter), a phenotype first observed in bitransgenic mice that express both SV40 T antigen and a receptor tyrosine kinase, the insulin-like growth factor (IGF) 1 receptor (IGF1R), in the pancreatic islets [23]. No significant effects of Bcl-xL on proliferative or apoptotic indices in the tumors were observed at 2 and 5 wk after viral delivery (data not shown). Thus, introducing RCASBP-Bcl-xL into RIP-Tag; RIP-tva mice with islet cell hyperplasia has a substantial impact on tumor burden, tumor incidence, and invasive potential within 2 wk after infection.
###end p 50
###begin title 51
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 89 93 <span type="species:ncbi:10090">Mice</span>
Confirmation of the Presence of RCASBP-Bcl-xL Proviral DNA in Tumors and Metastases from Mice Infected with RCASBP-Bcl-xL
###end title 51
###begin p 52
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 120 127 120 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050276-t001">Table 1</xref>
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">Figure 5</xref>
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">Figure 5</xref>
###xml 705 713 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g006">Figure 6</xref>
###xml 865 870 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 880 888 880 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g006">Figure 6</xref>
###xml 1092 1098 1092 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP,</italic>
###xml 1176 1192 1176 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
Since infection of bitransgenic mice with RCASBP-Bcl-xL increases the number of tumors by about 2-fold at 16 wk of age (Table 1; Figure 5), we anticipated that about half of the tumors would contain avian proviral DNA as evidence of infection that confers a selective growth advantage. To test this prediction, we isolated genomic DNA from freshly microdissected tumors or from tumors in paraffin-embedded sections, and we then performed PCR using primers specific to RCASBP sequences. Using materials from the experiment shown in Figure 5, we detected RCASBP DNA in eight of 11 tumors (72%), six of 12 tumors (50%), and ten of 25 tumors (40%) harvested 2, 5, and 9 wk after viral delivery, respectively (Figure 6A and data not shown). In contrast, RCASBP DNA was detectable in only two of 20 tumors from mice sacrificed 9 wk after infection with the control RCASBP-ALPP viruses (Figure 6B), which is consistent with an in vivo infection efficiency of at least 10%. These results support the hypothesis that infection leading to production of Bcl-xL, but not the control infection with RCASBP-ALPP, provides a selective growth advantage to islet cells during tumorigenesis in RIP-Tag; RIP-tva mice.
###end p 52
###begin title 53
PCR Analysis to Verify the Presence of the RCASBP Proviral DNA in the Tumors
###end title 53
###begin p 54
###xml 163 170 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 390 397 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 457 462 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
(A and B) Tumor DNAs were extracted from freshly microdissected tumors or paraffin-embedded pancreatic sections from mice 9 wk after mice were infected with RCASBP-Bcl-xL or RCASBP-ALPP. PCR was performed using RCASBP-specific primers or ACTB (beta-actin)-specific primers. The presence of RCASBP proviruses in the genomic DNA was detected in ten of 25 tumors from mice infected with RCASBP-Bcl-xL (A) and two of the 20 tumors from mice infected with RCASBP-ALPP (B).
###end p 54
###begin p 55
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 174 182 174 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
(C) The presence of RCASBP proviruses in the genomic DNA was detected in nine of nine pancreatic lymph node metastases from mice infected with RCASBP-Bcl-xL (n = 4) or RCASBP-dnE-cad (n = 5).
###end p 55
###begin p 56
+, RCASBP plasmid DNA used as template DNA in PCR; Normal, normal lymph node.
###end p 56
###begin p 57
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 456 464 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 498 504 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP,</italic>
###xml 724 731 724 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 741 749 741 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 751 759 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g006">Figure 6</xref>
###xml 844 852 844 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL-</italic>
###xml 862 870 862 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
Because only small amounts of DNA were obtained from these small tumors, we were unable to assess the clonality of tumors containing RCASBP-Bcl-xL by restriction mapping and thereby determine if they arose from the expansion of single infected cells. In addition, no suitable anti-Bcl-xL antibodies were found to identify tumors expressing Bcl-xL by immunohistochemistry. We observed lymph node metastases only in mice infected with RCASBP-Bcl-xL or RCASBP-dnE-cad, not in mice infected with RCASBP-ALPP, so we considered the possibility that metastases had arose from tumor cells expressing Bcl-xL or dnE-cad. We confirmed the presence of RCASBP proviral DNA in all nine lymph node metastases from mice infected with RCASBP-Bcl-xL or RCASBP-dnE-cad (Figure 6C). We cannot, however, claim that all the metastatic cells were derived from RCASBPP-Bcl-xL- or RCASBP-dnE-cad-infected cells.
###end p 57
###begin title 58
Bcl-xL Induces Changes in Cell Morphology, Migration, and Invasion In Vitro
###end title 58
###begin p 59
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b027">27</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b028">28</xref>
###xml 173 189 173 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 451 459 451 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 530 538 530 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g007">Figure 7</xref>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
Since tumor invasion and metastasis often involve modulation of the actin cytoskeleton to increase cell motility [27,28], we evaluated the actin cytoskeleton in tumors from RIP-Tag; RIP-tva mice infected with RCASBP-Bcl-xL, using an immunofluorescence assay with rhodamine-phalloidin to display filamentous actin (F-actin). We observed a dramatic rearrangement of the actin cytoskeleton in invasive carcinomas at 2 and 5 wk after infection with RCASBP-Bcl-xL, but not in tumors from age-matched animals infected with RCASBP-ALPP (Figure 7A), suggesting that Bcl-xL remodels the actin cytoskeleton to increase cell motility.
###end p 59
###begin title 60
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
Redistribution of the Actin Cytoskeleton in RCASBP-Bcl-xL-Infected Tumor Cells
###end title 60
###begin p 61
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
(A) Frozen pancreatic sections from a wild-type mouse (left panel), a mouse 2 wk after RCASBP-Bcl-xL infection (middle panel), and a mouse 5 wk after RCASBP-ALPP infection (right panel) were stained with rhodamine-phalloidin for F-actin (red) and DAPI (blue). The presence of RCASBP-Bcl-xL proviral DNA in the tumor (middle panel) was confirmed by PCR. Three mice each at 2 and 5 wk after RCASBP-Bcl-xL delivery and at 5 wk after RCASBP-ALPP delivery were analyzed. Ex, exocrine tissue; I, islet; Tu, tumor tissue.
###end p 61
###begin p 62
###xml 10 26 10 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP,</italic>
###xml 199 207 199 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 217 225 217 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 259 266 259 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 484 491 484 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
(B and C) RIP-Tag; RIP-tva tumor cells change morphology in vitro after being infected with RCASBP-Bcl-xL. (B) Bright-field images of uninfected tumor cells and cells infected with RCASBP-GFP, RCASBP-Bcl-xL, or RCASBP-dnE-cad. Tumor cells infected with RCASBP-Bcl-xL have a less organized epithelial sheet structure. Original magnification, 200x. (C) Tumor cells were cultured on chamber slides and immunostained with rhodamine-phalloidin for F-actin. Tumor cells infected with RCASBP-Bcl-xL have decreased cortical actin. Scale bars, 20 mum. The images are representative of more than ten fields in each experiment.
###end p 62
###begin p 63
###xml 141 157 135 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 175 182 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 236 244 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 254 259 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP,</italic>
###xml 349 357 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 482 486 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 496 504 490 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 506 514 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g007">Figure 7</xref>
###xml 664 672 658 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 704 712 698 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g007">Figure 7</xref>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
To further understand the effects of Bcl-xL on tumor cells, we infected a beta-cell tumor cell line (betaTC-N134) derived from an uninfected RIP-Tag; RIP-tva mouse with RCASBP-Bcl-xL. In addition, we infected the tumor cells with RCASBP-dnE-cad or RCASBP-GFP, to control for any effects of retroviral infection. Two weeks after infection with RCASBP-Bcl-xL, the tumor cells became more elongated compared to the uninfected parental cells and to the cells infected with either RCASBP-GFP or RCASBP-dnE-cad (Figure 7B). Staining with rhodamine-phalloidin demonstrated decreased cortical actin and a less organized epithelial sheet in tumor cells infected with RCASBP-Bcl-xL, but not in the other cultures (Figure 7C). Taken together, these results suggest that Bcl-xL promotes remodeling of the actin cytoskeleton, affecting cell shape and adhesion.
###end p 63
###begin p 64
###xml 255 260 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP,</italic>
###xml 267 275 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 285 293 282 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 580 587 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 597 605 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 701 705 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 707 715 703 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
###xml 902 909 897 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 997 1006 992 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad,</italic>
###xml 1082 1086 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 1114 1122 1109 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
To examine whether Bcl-xL increased the ability of morphologically altered cells to migrate or invade, we performed two-chamber migration and invasion assays. In the migration assay, uninfected tumor cells (betaTC-N134) or tumor cells infected with RCASBP-GFP, RCASBP-Bcl-xL, or RCASBP-dnE-cad were seeded in the upper chambers of transwell inserts with 8-mum porous polycarbonate membranes. We then measured cell migration along a serum gradient through the membrane to the bottom of the chambers. After a 72-h incubation, the number of migratory tumor cells infected with RCASBP-Bcl-xL or RCASBP-dnE-cad was approximately 1,000-fold higher than that of uninfected cells or cells infected with RCASBP-GFP (Figure 8A). In the invasion assay, 8-mum porous polycarbonate membranes were replaced with polyester membranes coated with basement membrane matrix, Matrigel. The tumor cells infected with RCASBP-Bcl-xL invaded through Matrigel about 20-fold more efficiently than those infected with RCASBP-dnE-cad, and none of the uninfected parental cells or the cells infected with RCASBP-GFP had the ability to invade (Figure 8B). The results reveal that Bcl-xL has profound effects on cell migration and invasion in vitro.
###end p 64
###begin title 65
Bcl-xL Has Profound Effects on Cell Migration and Invasion, and Reduces Cadherin 1 In Vitro
###end title 65
###begin p 66
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP,</italic>
###xml 109 117 109 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
(A and B) Cell migration and invasion. Uninfected tumor cells or tumor cells infected with RCASBP-GFP, RCASBP-Bcl-xL, or RCASBP-dnE-cad were plated in the upper chambers of transwell plates (A) or of Matrigel invasion plates (B). Data are presented as the mean numbers of cells counted in the lower chambers in five fields under 20x magnification after 72 h, and are representative of three independent experiments.
###end p 66
###begin p 67
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP,</italic>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 200 208 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
(C and D) Proliferative and apoptotic indices of the four different cell lines. Cultures grown on chamber slides from uninfected tumor cells or cells infected with RCASBP-GFP, RCASBP-Bcl-xL, or RCASBP-dnE-cad were stained with antisera against Ki67 (C) or activated caspase 3 (D). Data shown are the mean percentage +/- standard deviation from triplicate experiments.
###end p 67
###begin p 68
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 227 234 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
(E) Reduced protein levels of cadherin 1 and elevated snail homolog 1 levels in the tumor cell lines infected with RCASBP-Bcl-xL. Whole cell extracts (WCE; 20 mug) from uninfected tumor cells or tumor cells infected with RCASBP-Bcl-xL were analyzed by Western blotting using antisera against the cytosolic domain of cadherin 1 (clone 36), snail homolog 1, and Bcl-xL. Actin was measured as a loading control.
###end p 68
###begin p 69
###xml 169 177 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
(F) Two anti-cadherin 1 antibodies (clones ECCD-2 and 36) were used to perform IP from whole cell extracts of uninfected tumor cells and tumor cells infected with RCASBP-dnE-cad or RCASBP-Bcl-xL. The precipitates were subjected to Western blotting using an antibody against the cytosolic domain of cadherin 1 (clone 36). Two lanes without WCE were used to identify the bands attributable to IgGs (lanes 7 and 11). A portion of nitrocellulose membrane stained with Ponceau S is shown as a loading control.
###end p 69
###begin p 70
###xml 474 482 474 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">8</xref>
###xml 542 550 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g005">Figure 5</xref>
To ensure that any increase in cell migration and invasion in vitro was not simply due to an increase of cell number by the anti-apoptotic effect of Bcl-xL, immunocytochemistry using antibodies for Ki67 and activated caspase 3 was performed to assay cell proliferation and cell survival. The frequency of Ki67-positive cells and activated-caspase-3-positive cells remained similar in all three of the infected tumor cell lines compared to the uninfected parental cell line (Figure 8C and 8D). These results, consistent with our in vivo data (Figure 5A), suggest that Bcl-xL is able to promote cell migration and invasion without changing cell proliferation or survival.
###end p 70
###begin title 71
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
Reduction of Endogenous Cadherin 1 in Tumor Cells Infected with RCASBP-Bcl-xL
###end title 71
###begin p 72
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b022">22</xref>
###xml 217 225 217 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 327 335 327 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
###xml 420 428 420 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 485 495 485 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cadherin 1</italic>
###xml 571 579 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b029">29</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b030">30</xref>
###xml 858 866 858 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 876 883 876 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b031">31</xref>
###xml 1180 1188 1180 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
###xml 1322 1330 1322 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 1332 1340 1332 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
###xml 1447 1454 1447 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1456 1464 1456 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
###xml 1022 1027 <span type="species:ncbi:9606">human</span>
###xml 1065 1070 <span type="species:ncbi:10090">mouse</span>
###xml 1108 1113 <span type="species:ncbi:10090">mouse</span>
In addition to the cytoskeleton rearrangement, loss of cadherin 1 can also confer invasive properties on tumor cells [22]. To examine if the expression of cadherin 1 was altered in the tumor cells infected with RCASBP-Bcl-xL, we measured cadherin 1 levels by Western blot analysis using an anti-cadherin 1 antibody (clone 36) (Figure 8E). Cadherin 1 protein was much less abundant in the tumor cells infected with RCASBP-Bcl-xL, suggesting that overexpression of Bcl-xL down-regulates cadherin 1. We also observed moderately increased amounts of snail homolog 1 protein (Figure 8E), a transcriptional repressor of cadherin 1 [29,30]. We also performed immunoprecipitation (IP) experiments using two anti-cadherin 1 antibodies (clones ECCD-2 and 36) and whole cell extracts prepared from the uninfected tumor cells or from the tumor cells infected with RCASBP-dnE-cad or RCASBP-Bcl-xL. The immuoprecipitates were subjected to Western blotting using the clone 36 antibody, which was raised against the cytoplasmic domain of human cadherin 1 and cross-reacts with the mouse homolog. ECCD-2 was raised against a mouse liver cadherin 1 fragment [31], and it did not recognize dnE-cad (Figure 8F, lane 4). The levels of endogenous cadherin 1 were not affected by overexpression of dnE-cad in the tumor cells infected with RCASBP-dnE-cad (Figure 8F, lane 1). In marked contrast, cadherin 1 was considerably reduced in the tumor cells infected with RCASBP-Bcl-xL (Figure 8F, lanes 3, 6, and 10).
###end p 72
###begin p 73
###xml 228 244 228 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 393 403 393 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cadherin 1</italic>
###xml 543 550 543 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1017 1025 1014 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g008">Figure 8</xref>
To determine whether regulation of cadherin 1 levels was a result of lowered mRNA levels, we surveyed tumor cell RNAs with oligonucleotide arrays (Affymetrix). We observed that the levels of cadherin 1 RNA were 36-fold lower in RIP-Tag; RIP-tva tumor cells infected with RCASBP-Bcl-xL than in uninfected parental cells (data not shown), suggesting that Bcl-xL is likely to lower expression of cadherin 1 at the transcriptional level. Surprisingly, we did not detect a significant reduction of cadherin 1 on the tumor cells infected with RCASBP-Bcl-xL by immunostaining assays, using the two anti-cadherin 1 antibodies (data not shown), raising questions about the specificity of the antibodies used in the assays. Taken together, overexpression of Bcl-xL reduces the levels of cadherin 1 RNA and protein, and loss of cadherin 1 is likely to contribute to cell migration and invasion. However, suppression of cadherin 1 function by dnE-cad is not as efficient as Bcl-xL in promoting invasion of beta-cell tumor cells (Figure 8B).
###end p 73
###begin title 74
Bcl-xL Interacts with Myosins
###end title 74
###begin p 75
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b032">32</xref>
###xml 283 291 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 747 755 747 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 977 984 977 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
The assembly and organization of the actin cytoskeleton can be regulated by small guanosine triphosphatases (GTPases) [32]. We evaluated whether the activities of four members of the small GTPase family (RHO, CDC42, RAC1, and RAS) were changed in the tumor cells infected with RCASBP-Bcl-xL, by measuring the signaling activities of these four small GTPases as reflected in the binding of GTP. Their specific effector proteins were expressed as glutathione S-transferase (GST)-fusion proteins to pull down GTP-bound GTPases, which were detected by Western blotting using antibodies against specific GTPases. However, no significant changes in the signaling strength of RHO, CDC42, RAC1, or RAS were detected in the tumor cells infected with RCASBP-Bcl-xL, compared with the uninfected parental cells (data not shown), indicating that altered activities of these four proteins were not responsible for the remodeling of the actin skeleton in the tumor cells infected with RCASBP-Bcl-xL. We cannot exclude the possibilities that small GTPase activities vary spatially within the cells or that other members of the family are responsible for the reorganization of the actin cytoskeleton when Bcl-xL is overexpressed.
###end p 75
###begin p 76
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b033">33</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b034">34</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b035">35</xref>
###xml 511 518 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1002 1010 1002 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g009">Figure 9</xref>
To further investigate the mechanism by which Bcl-xL increases cell motility, we sought to identify Bcl-xL-interacting proteins by mass spectrometry. Bcl-xL is located both in the cytosol and in mitochondrial membranes [33,34], whereas BCL2, a related anti-apoptotic protein, is exclusively membrane-bound [35]. We postulated that the cytosolic fraction of Bcl-xL might contribute to its effects on cell shape, motility, and invasiveness, so we prepared whole cell extracts from tumor cells infected with RCASBP-Bcl-xL in two buffer conditions, and used an anti-Bcl-xL antibody to co-precipitate interacting proteins. The antibody-bound complexes were eluted from beads by boiling, separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and visualized by silver staining. Although many protein bands were present in the IP, we observed that the intensities of several protein bands, including Bcl-xL itself, were enhanced with increasing amounts of an anti-Bcl-xL antibody (Figure 9A). These putative Bcl-xL-interacting bands were excised and subjected to tryptic digestion, and peptides were analyzed by mass spectrometry. The identities of the proteins were BAX, myosin Va, and myosin, heavy polypeptide 9, non-muscle isoform 1.
###end p 76
###begin title 77
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
Bcl-xL Interacts with BAX, Unphosphorylated BAD, and Myosin Va in the Tumor Cells Infected with RCASBP-Bcl-xL
###end title 77
###begin p 78
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 140 141 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 273 278 <span type="species:ncbi:9606">human</span>
(A) Whole cell extracts of tumor cells infected with RCASBP-Bcl-xL were prepared in cell lysis buffer containing 150 mM NaCl or 100 mM (NH4)2SO4 (L100 buffer), and subjected to IP with increasing amounts of an anti-Bcl-xL antibody. The precipitates and 5 ng of recombinant human Bcl-xL (rBcl-xL) were analyzed by SDS-PAGE and silver staining. The putative Bcl-xL-interacting bands (open arrowheads) were excised from the gel for mass spectrometry. The identities of the proteins are listed. Both myosin Va and myosin, heavy polypeptide 9, non-muscle isoform 1 were identified by mass spectrometry using proteins from the excised area labeled "(1)."
###end p 78
###begin p 79
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 442 449 442 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
(B) Whole cell extracts of uninfected tumor cells and tumor cells infected with RCASBP-Bcl-xL were prepared in L100 buffer, and subjected to IP with an anti-Bcl-xL antibody. The precipitates were analyzed by SDS-PAGE and Western blotting using specific antibodies against Bcl-xL, BAX, BAD, phospho-BAD, myosin Va, and actin. Four of these proteins, Bcl-xL, BAX, BAD, and myosin Va, were found in anti-Bcl-xL IP from cells infected with RCASBP-Bcl-xL.
###end p 79
###begin p 80
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b036">36</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b037">37</xref>
###xml 436 443 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 468 476 465 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g009">Figure 9</xref>
###xml 564 572 561 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g009">Figure 9</xref>
###xml 671 678 668 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
The current view of apoptotic regulation is that Bcl-xL and its relatives bind to and thereby inhibit the pro-apoptotic activity of BAX and BAK1, which are otherwise poised to initiate the apoptotic cell death cascade [36,37]. Activated BH3 sensors, such as BAD, bind to Bcl-xL-related proteins, relieving suppression of BAX and BAK1. We confirmed the interaction between BAX and Bcl-xL in the beta-cell tumor cells infected with RCASBP-Bcl-xL by IP-Western blotting (Figure 9B). We also observed an interaction between Bcl-xL and BAD, but not phosphorylated BAD (Figure 9B). The significance of the reduction of phosphorylated BAD in the tumor cells infected with RCASBP-Bcl-xL remains to be determined.
###end p 80
###begin p 81
###xml 105 113 105 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g009">Figure 9</xref>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050276-g009">Figure 9</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b038">38</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b040">40</xref>
We obtained an antibody against myosin Va and confirmed the presence of myosin Va in the anti-Bcl-xL IP (Figure 9B), suggesting that the interaction between Bcl-xL and myosin Va was specific and significant. No suitable antibodies against the other implicated myosin were found, so Western blotting to verify its specificity by IP from the cells infected with RCASBP-Bcl-xL was not possible. Furthermore, the association between Bcl-xL and myosin Va was unlikely to be mediated by the actin cytoskeleton, because actin was not present in Bcl-xL IP (Figure 9B). Myosins have been implicated in cell movement and migration [38-40], and therefore it is possible that Bcl-xL promotes cell motility through its interaction with myosins.
###end p 81
###begin title 82
Discussion
###end title 82
###begin p 83
###xml 247 263 244 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 787 803 781 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 707 722 <span type="species:ncbi:10090">transgenic mice</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
The studies presented here demonstrate a system to transfer cDNAs into premalignant lesions in mice to analyze their effects on tumor progression. This system utilizes RCASBP avian retroviral vectors to deliver cDNAs into pancreatic beta cells in RIP-Tag; RIP-tva bitransgenic mice during tumorigenesis. This approach has the advantage of introducing somatic genetic changes in a tissue-specific and time-controlled fashion, which more faithfully mimics sporadic tumor development. It also avoids any potential perturbation of normal tissue formation due to the ectopic expression of the gene of interest during development. It is much faster to generate vectors carrying genes of interest than to generate transgenic mice. In addition, using cell lines derived from beta-cell tumors in RIP-Tag; RIP-tva bitransgenic mice, further biochemical and phenotypic analysis can be performed, taking advantage of the high efficiency of viral infection in vitro.
###end p 83
###begin p 84
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b013">13</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b014">14</xref>
###xml 245 246 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 472 488 469 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 627 643 624 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 702 709 699 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 764 780 761 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1007 1023 1004 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
The low efficiency of in vivo infection has been a limitation of using the RCAS-TVA system [13,14]. Here, we were able to achieve 10%-20% in vivo infection efficiency in hyperplastic pancreatic islet beta-cell lesions using high viral titer (>108 infectious units per milliliter) and the intra-cardiac route to deliver the RCASBP viruses into mice. Since not all the premalignant lesions are infected with the RCASBP vectors and 2%-4% of islets develop into tumors in the RIP-Tag; RIP-tva bitransgenic mice without viral infection, only the factors that confer a selective advantage over the natural course of tumorigenesis in RIP-Tag; RIP-tva mice can be identified. Moreover, the percentage of RCASBP-Bcl-xL-positive tumors decreases over time as the uninfected RIP-Tag; RIP-tva cells gradually develop into tumors. In particular, RCASBP vectors carrying genes that promote metastasis will be most easily recognized, because metastasis to pancreatic lymph nodes or other organs does not normally occur in RIP-Tag; RIP-tva mice. Although tumors are likely to be clonally expanded from single cells infected with RCASBP vectors carrying progression factors, we were not able to show whether the tumors were clonal because of the limited DNA materials isolated from the small tumors in this study.
###end p 84
###begin p 85
###xml 68 84 68 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 195 218 195 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2; RIP1-dnE-cad</italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b022">22</xref>
###xml 286 294 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 327 343 327 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 841 843 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b041">41</xref>
###xml 844 846 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b042">42</xref>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">Mice</span>
We delivered RCASBP viruses carrying tumor progression factors into RIP-Tag; RIP-tva bitransgenic animals at 7 wk of age, when hyperplastic islets develop. Analogous to the results obtained from RIP1-Tag2; RIP1-dnE-cad bitransgenic mice [22], we demonstrated that introduction of RCASBP-dnE-cad into the hyperplastic islets of RIP-Tag; RIP-tva animals promoted invasive tumor formation and metastases to the pancreatic lymph nodes. Mice at other ages could also be used to study whether the time at which the candidate factors are introduced influences the outcome, as long as islet cells undergo cell division to allow infection. For example, the transforming growth factor beta1 (TGFB1) receptor can act as a tumor suppressor at early stages of tumor development, but at later stages TGFB1 responsiveness promotes invasion and metastasis [41,42]. Moreover, a combination of several RCASBP viruses encoding different factors of interest could be used for infection simultaneously or sequentially, and the proviral DNA could be isolated from especially metastatic malignant tumors to identify single factors or combinations of factors that may contribute to the malignancy. However, this approach is limited by the inability of the RCASBP vector to accommodate cDNAs greater than 2.5 kb in size.
###end p 85
###begin p 86
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 463 472 460 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 480 482 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b025">25</xref>
###xml 520 522 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b026">26</xref>
###xml 690 696 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 1151 1160 1145 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1423 1425 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b023">23</xref>
###xml 1606 1608 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b043">43</xref>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 503 518 <span type="species:ncbi:10090">transgenic mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
The effects of overproducing Bcl-xL via somatic gene transfer were provocative and unexpected. First, no significant protection against apoptosis was found either in the tumors from mice infected with RCASBP-Bcl-xL or in the tumor cells infected with RCASBP-Bcl-xL in vitro. These findings are quite distinct from the demonstrable anti-apoptotic effect seen when Bcl-xL was expressed via a transgene in all islet beta cells throughout tumorigenic ontogeny in the RIP1-Tag2 model [25], as well as in MYC transgenic mice [26]. It remains possible that Bcl-xL contributes to cell survival at earlier stages (hyperplasia/angiogenesis) or a later stage (metastasis) in mice infected with RCASBP-Bcl-xL. Additionally, we cannot exclude episodic effects on apoptosis when tumors were forming, as opposed to chronic effects detectable at the later time points of our analysis. This apparent insensitivity of beta-cell tumors to the anti-apoptotic effect of Bcl-xL deserves future investigation. Notably, a similar phenotype of increased invasiveness without suppression of apoptosis has been observed when another apoptotic modulator was overexpressed in the RIP1-Tag2 mice. Exogenous production of IGF1R for the IGF1/2 survival factors in all islet beta cells caused increased invasiveness and lymph node metastasis, with increased (not decreased) apoptosis in the premalignant stages, while having no impact on the tumor stages [23]. Yet elimination of the gene encoding IGF2 produced highly apoptotic tumors with reduced growth, demonstrating the importance of anti-apoptotic signaling for islet tumorigenesis [43]. The similar consequences of ectopically expressing Bcl-xL and IGF1R may imply mechanistic similarity that should be further explored.
###end p 86
###begin p 87
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL,</italic>
###xml 203 210 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
Second, we observed that the actin cytoskeleton was rearranged in invasive tumors infected with RCASBP-Bcl-xL, presumably contributing to increased motility. In addition, tumor cells infected with RCASBP-Bcl-xL in vitro displayed altered morphology, abnormal cortical distribution of the actin cytoskeleton, and elongated cell shape. The morphological changes in tumor cells infected with RCASBP-Bcl-xL may contribute to enhanced cell migration and invasion as observed in the two-chamber assays.
###end p 87
###begin p 88
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 448 455 448 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
Third, as measured by Western blotting and cDNA microarray expression profiling, the epithelial cell-cell junction protein, cadherin 1, was down-regulated and a transcriptional repressor of cadherin 1, snail homolog 1, was up-regulated in the tumor cells infected with RCASBP-Bcl-xL. These changes may contribute to the rearrangement of the actin cytoskeleton and diminish the strength of cellular adhesion. Indeed, tumor cells infected with RCASBP-Bcl-xL exhibited a strong capability to migrate through transwell membrane and to invade through Matrigel, but the mechanism by which Bcl-xL regulates cadherin 1 remains to be determined.
###end p 88
###begin p 89
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b039">39</xref>
###xml 896 910 896 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dictyostelium,</italic>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b044">44</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b045">45</xref>
Finally, the identification of a novel Bcl-xL-interacting protein, myosin Va, may help to explain the pro-invasive activity of Bcl-xL. Myosins belong to a superfamily of actin-based motor proteins comprising at least 15 classes [39]. There are two main groups of myosins: the conventional, well-characterized myosin II class of muscle and non-muscle cells and the unconventional myosins. The myosin II class is referred to as "conventional myosin" because for many years this was the only class of myosin known; members of this class are able to form filaments and are involved in muscle contraction, cell migration, and cytokinesis. The functions of most of the unconventional myosins are not known, but some have been shown to participate in the extension of processes at the leading edge of crawling cells. For example, myosin I is required for formation of pseudopod extensions in the amoeba Dictyostelium, and myosin V for extension of filopodia in neurons [44,45].
###end p 89
###begin p 90
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b046">46</xref>
###xml 369 371 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b022">22</xref>
###xml 924 931 921 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1110 1126 1107 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1152 1159 1149 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 1170 1178 1167 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad</italic>
###xml 1359 1361 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b047">47</xref>
###xml 352 367 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1344 1349 <span type="species:ncbi:10090">mouse</span>
By comparing the effects of suppressing the function of cadherin 1 with dnE-cad and overproducing Bcl-xL, we have highlighted the provocative pro-invasive activity of Bcl-xL. Cadherin 1 is a well-established barrier to invasive growth in many other epithelial cancers [46], and its suppression enables invasive growth of pancreatic beta-cell tumors in transgenic mice [22]. Yet Bcl-xL produced a more highly invasive phenotype in a Matrigel invasion assay of cultured tumor cells than did dnE-cad, supporting the proposition that Bcl-xL has roles other than suppression of cadherin 1 that enhance the invasive growth phenotype. The levels of endogenous cadherin 1 in these two types of cells could contribute to the differences. Whereas endogenous cadherin 1 protein levels were not affected when the dominant-negative form was introduced into the cells, cadherin 1 was down-regulated in the tumor cells infected with RCASBP-Bcl-xL. This effect could reduce cell-cell adhesion and also affect the organization of the actin cytoskeleton. On the other hand, the frequency of lymph node metastasis was similar in RIP-Tag; RIP-tva mice infected with RCASBP-Bcl-xL and RCASBP-dnE-cad. It is possible that the beta-cell tumor microenvironment in vivo is less discriminating than Matrigel, a solubulized basement membrane preparation extracted from a mouse sarcoma [47].
###end p 90
###begin p 91
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b048">48</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b049">49</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b050">50</xref>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl2</italic>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b051">51</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b052">52</xref>
###xml 598 607 <span type="species:ncbi:10090">nude mice</span>
###xml 636 641 <span type="species:ncbi:9606">human</span>
The BCL2 family proteins function in carcinogenesis by preventing apoptosis of tumor cells, instead of promoting cell proliferation [48]. Of the BCL2 family members, BCL2 and Bcl-xL are most closely related to each other, and repress cell death through common mechanisms [49,50]. However, several lines of evidence indicate that they are not functionally equivalent in tumorigenesis. In primary breast cancer, overexpression of Bcl-xL is associated with higher tumor grade and nodal metastasis, and overexpression of Bcl2 is correlated with lower tumor grade and smaller tumor size [51]. Moreover, nude mice with orthotopic implants of human breast cancer cells transfected with Bcl-xL, but not BCL2, develop lymph node metastasis [52]. Our findings suggest that Bcl-xL enhances cell motility, remodels the actin cytoskeleton, down-regulates cadherin 1, and interacts with myosin Va without affecting cell proliferation or apoptosis. It remains to be investigated whether these properties are unique to Bcl-xL among the BCL2 family members.
###end p 91
###begin p 92
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 777 792 <span type="species:ncbi:10090">transgenic mice</span>
In conclusion, we have developed a mouse model to assess the effect of candidate genes in tumor progression, without the need to generate conditional transgenic lines in which genes of interest are expressed at different stages of tumorigenesis. Thus far, we have employed this approach to improve our knowledge of the contribution of Bcl-xL to tumor invasion and metastasis. We postulate that Bcl-xL has a pro-invasive function other than its anti-apoptotic activity. Given that many somatic gene mutations and altered expression of thousands of genes have been discovered in cancers, it will not be a simple task to verify that each candidate gene is important during carcinogenesis. By delivering libraries of retroviruses encoding candidate factors or inhibitory RNAs into transgenic mice, it may be possible to screen many of the genes for effects during tumorigenesis in a variety of tissues.
###end p 92
###begin title 93
Materials and Methods
###end title 93
###begin title 94
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse strains.
###end title 94
###begin p 95
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tva</italic>
###xml 38 40 38 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b053">53</xref>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tva</italic>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tva</italic>
###xml 421 424 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tva</italic>
###xml 626 633 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 782 789 782 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 931 938 931 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 987 996 987 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP1-Tag2</italic>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b011">11</xref>
###xml 1017 1033 1017 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 543 547 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1034 1038 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
The elastase-tva transgene construct [53] was digested with BamHI and HindIII to release a 800-bp tva cDNA fragment encoding the glycosylphosphatidylinisotol-anchored form of the receptor. This cDNA fragment was cloned into a BglII- and HindIII-digested pSG5 vector with an expanded multiple cloning site (gift of E. Emison, Johns Hopkins University). The tva cDNA was then released by XbaI/HindIII digestion of the pSG5-tva plasmid and subcloned into a XbaI/HindIII-digested RIP-DIPA plasmid that contains the RIP 5' to the XbaI site and the SV40 small t intron and terminator sequences 3' to the HindIII site. The resulting RIP-tva transgene construct was released from the pBR322 vector backbone by digestion with BamHI, purified, and resuspended in TE for pronuclear injection. RIP-tva transgenic founders on a CBA/CAJ x C57BL/6 mixed genetic background were backcrossed for ten generations onto a pure C57BL/6 background. The RIP-tva mice were crossed with the previously described RIP1-Tag2 mice [11] to obtain RIP-Tag; RIP-tva mice. All mice were housed in accordance with institutional guidelines. Genotypes were determined by PCR using tail DNA. PCR primers for TVA were 5'-GCCCTGGGGAAGGTCCTGCCC-3' and 5'- CTGCTGCCCGGTAACGTGACCGG-3'.
###end p 95
###begin title 96
beta-cell tumor cell line.
###end title 96
###begin p 97
###xml 85 101 79 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 345 346 333 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 370 372 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b054">54</xref>
###xml 225 231 <span type="species:ncbi:9913">bovine</span>
A pancreatic beta-cell tumor cell line (betaTC-N134) was derived from a tumor from a RIP-Tag; RIP-tva bitransgenic animal at 16 wk of age, and maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 0.2 mM L-glutamine, and 1% penicillin/streptomycin in a humidified 37 degreesC incubator under 5% CO2; method modified from [54].
###end p 97
###begin title 98
Viral propagation and delivery.
###end title 98
###begin p 99
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-ALPP</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b055">55</xref>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-GFP</italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dnE-cad</italic>
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL</italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b056">56</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b057">57</xref>
###xml 761 762 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 912 928 905 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag; RIP-tva</italic>
###xml 1238 1240 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b058">58</xref>
###xml 34 54 <span type="species:ncbi:11864">avian leukosis virus</span>
###xml 92 95 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 241 246 <span type="species:ncbi:9606">Human</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 545 552 <span type="species:ncbi:9031">Chicken</span>
###xml 1180 1184 <span type="species:ncbi:10090">mice</span>
RCASBP is a replication-competent avian leukosis virus with a splice acceptor and the Bryan-RSV pol gene. RCASBP-ALPP has been described previously [55]. RCASBP-GFP was a gift from Maureen Peters and Constance Cepko, Harvard Medical School. Human Bcl-xL cDNA was a gift from Stanley Korsmeyer, Dana-Farber Cancer Institute. RCASBP-dnE-cad (myc-tagged, mouse origin) and RCASBP-Bcl-xL were generated by Yi Li and William Pao, respectively, in the Varmus laboratory. The production of the dnE-cad and Bcl-xL was verified by Western blot analysis. Chicken fibroblasts DF-1 [56,57] transfected with RCASBP vectors were maintained in DMEM supplemented with 10% FBS, 0.2 mM L-glutamine, and 1% penicillin/streptomycin in a humidified 37 degreesC incubator under 5% CO2. For in vitro infection, RCASBP viral supernatant was passed through a 0.45-mum filter to obtain cell-free viruses and used as growth medium for the RIP-Tag; RIP-tva pancreatic beta-cell tumor cell line once a day for 2-3 d. For in vivo infection, viral supernatant was passed through 0.45-mum filters and was concentrated by high-speed ultracentrifugation at 23,000 rpm for 1.5 h before intra-cardiac injection into mice. Intra-cardiac injection was performed as described [58]. Viral titer was determined by end-point dilution of DF-1 producer cells. PCR primers for RCASBP were 5'-ACCGGGGGATGCGTAGGCTTCA-3' and 5'-CCGCAACACCCACTGGCATTACC-3'.
###end p 99
###begin title 100
Tissue preparation.
###end title 100
###begin p 101
Tissues were removed and either fixed in 10% buffered formalin overnight at room temperature or immediately placed in OCT and frozen on dry ice. Fixed and frozen tissues were processed and cut into 5-mum and 10-mum sections, respectively, at Histoserv ().
###end p 101
###begin title 102
Immunohistochemical analysis.
###end title 102
###begin p 103
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
###xml 488 492 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 526 532 <span type="species:ncbi:9986">rabbit</span>
###xml 569 575 <span type="species:ncbi:9986">rabbit</span>
###xml 612 618 <span type="species:ncbi:9986">rabbit</span>
###xml 677 683 <span type="species:ncbi:9986">rabbit</span>
Formalin-fixed/paraffin-embedded sections were deparaffinized and rehydrated by passage through a graded xylene/ethanol series before staining. Cells were cultured on glass chamber slides for 3 d before fixation in 4% paraformaldehyde in PBS for 20 min, and were permeabilized by 0.1% Triton X-100 (in PBS) for 4 min. Immunochemistry with VECTASTAIN Elite ABC Kit (Vector Laboratories, ) was performed according to the manufacturer's instructions. Primary antibodies used were mouse anti-SV40 T antigen (1:400; Calbiochem, ), rabbit anti-insulin (1:600; Immunostar, ), rabbit anti-synaptophysin (1:100; Dako, ), rabbit anti-Ki67 (1:1,000; Novocastra, Vision BioSystems, ), and rabbit anti-activated caspase 3 (1:100; Cell Signaling Technology, ).
###end p 103
###begin title 104
Immunofluorescent analysis.
###end title 104
###begin p 105
###xml 649 655 <span type="species:ncbi:9986">rabbit</span>
###xml 738 742 <span type="species:ncbi:9925">goat</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 868 874 <span type="species:ncbi:9793">donkey</span>
###xml 880 886 <span type="species:ncbi:9986">rabbit</span>
###xml 908 914 <span type="species:ncbi:9793">donkey</span>
###xml 920 924 <span type="species:ncbi:9925">goat</span>
Frozen sections were air-dried overnight at room temperature and fixed in cold acetone for 10 min. Formalin-fixed/paraffin-embedded sections were deparaffinized and rehydrated by passage through a graded xylene/ethanol series. Cells were cultured on glass chamber slides for 3 d before fixation in 4% paraformaldehyde in PBS for 20 min, and permeabilized by 0.1% Triton X-100 (in PBS) for 4 min. After blocking, slides were incubated with primary antibodies overnight at 4 degreesC or for 1 h at room temperature. After three washes of TBS-T, slides were incubated with secondary antibodies for 1 h at room temperature. Primary antibodies used were rabbit anti-TVA (1:200; gift of Andrew Leavitt, University of California San Francisco), goat anti-mouse PDX1 (1:2,000; gift of Chris Wright, Vanderbilt University), and rhodamine-phalloidin (1:40; Invitrogen, ). TRITC-donkey anti-rabbit IgG (1:200) and FITC-donkey anti-goat IgG (1:200) were purchased from Jackson ImmunoResearch Laboratories (). To stain DNA, slides were incubated with DAPI (4',6-diamidino-2-phenylindole; 5 mug/ml in PBS) for 15 min at room temperature.
###end p 105
###begin title 106
FACS.
###end title 106
###begin p 107
###xml 207 209 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b019">19</xref>
###xml 366 368 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b020">20</xref>
###xml 394 400 <span type="species:ncbi:9793">donkey</span>
###xml 459 465 <span type="species:ncbi:9986">rabbit</span>
###xml 527 533 <span type="species:ncbi:9793">donkey</span>
###xml 554 560 <span type="species:ncbi:9986">rabbit</span>
Pancreases were perfused and digested into small pieces with collagenase (Sigma-Aldrich, ) at 37 degreesC for 15 min, and were centrifuged in a Ficoll gradient (11%, 20.5%, 23%, and 25% [w/v]) as described [19]. Partially digested pancreatic tissues in the top two layers of the gradient were further digested and dispersed into single-cell suspension as described [20]. After blocking with 3% donkey serum at 4 degreesC for 30 min, cells were incubated with rabbit anti-TVA antibodies at 4 degreesC for 30 min, incubated with donkey Cy5-conjugated anti-rabbit antibodies at 4 degreesC for 30 min, and analyzed for Cy5 and GFP by FACS using a BD Biosciences () FACS-DiVa Cell Sorter or FACSCalibur flow cytometer.
###end p 107
###begin title 108
Western blot analysis.
###end title 108
###begin p 109
###xml 339 345 <span type="species:ncbi:9986">rabbit</span>
###xml 405 410 <span type="species:ncbi:10090">mouse</span>
###xml 473 479 <span type="species:ncbi:9986">rabbit</span>
###xml 526 532 <span type="species:ncbi:9986">rabbit</span>
###xml 575 581 <span type="species:ncbi:9986">rabbit</span>
###xml 638 644 <span type="species:ncbi:9986">rabbit</span>
###xml 701 706 <span type="species:ncbi:10090">mouse</span>
###xml 780 786 <span type="species:ncbi:9986">rabbit</span>
To prepare whole cell extracts, cells were lysed in buffer containing 100 mM NaCl, 100 mM Tris (pH 8.2), 0.5% NP-40, and protein inhibitor cocktail at 4 degreesC. Then 20 mug of total proteins were separated by SDS-PAGE and electrotransferred onto nitrocellulose membranes. The membranes were stained with Ponceau S and immunoblotted with rabbit anti-Bcl-xL antibody (1:1,000; Cell Signaling Technology), mouse anti-cadherin 1 antibody (clone 36, 1:1,000; BD Biosciences), rabbit anti-actin antibody (1:5,000; Sigma-Aldrich), rabbit anti-snail homolog 1 (1: 1,000; Abcam, ), rabbit anti-BAX antibody (1:1,000; Cell Signaling Technology), rabbit anti-BAD antibody (1:1,000; Cell Signaling Technology), mouse anti-phospho-BAD (Ser112) antibody (1:1,000; Cell Signaling Technology), rabbit anti-myosin Va antibody (1:1,000; Sigma-Aldrich), and appropriate secondary antibodies. The proteins were detected with ECL chemiluminescent substrate (GE Healthcare, ) on Kodak () BioMax MR films.
###end p 109
###begin title 110
In vitro migration and invasion assays.
###end title 110
###begin p 111
###xml 528 529 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Transwell chambers with 8-mum porous polycarbonate membranes (Corning, ) and invasion chambers with 8-mum porous polyester membranes and coated with Matrigel basement membrane matrix (BD Biosciences) were used. One million cells were plated in the upper chambers in DMEM containing 2% FBS, 0.2 mM L-glutamine, and 1% penicillin/streptomycin. The lower chambers were filled with DMEM containing 10% FBS, 0.2 mM L-glutamine, and 1% penicillin/streptomycin. After a 72-h incubation in a humidified 37 degreesC incubator under 5% CO2, cells migrating or invading into the bottom chambers were fixed, stained with hematoxylin, and counted in five fields under 200x magnification.
###end p 111
###begin title 112
IP.
###end title 112
###begin p 113
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b059">59</xref>
###xml 860 862 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050276-b060">60</xref>
###xml 357 363 <span type="species:ncbi:9986">Rabbit</span>
###xml 656 661 <span type="species:ncbi:9606">human</span>
To prepare whole cell extracts for anti-Bcl-xL IP, cells were lysed in cell lysis buffer containing 150 mM NaCl according to the manufacturer's instructions from Cell Signaling Technology or in L100 buffer [59] containing protein inhibitor cocktail at 4degreesC for 30 min. The extracts were precleared with protein A Sepharose beads for 1 h at 4 degreesC. Rabbit anti-Bcl-xL antibody (Cell Signaling Technology) was mixed with the extracts for at least 4 h at 4 degreesC, and then protein A Sepharose beads were added for 1 h at 4 degreesC. The precipitates were washed extensively and were eluted from the beads by boiling in Laemmli buffer. Recombinant human Bcl-xL and BCL2 proteins were purchased from R&D Systems (). Anti-cadherin 1 IP using two anti-cadherin 1 antibodies-clone ECCD-2 (Zymed, ) and clone 36 (BD Biosciences)-was performed as described [60] except that protein A/G plus-agarose (Santa Cruz Biotechnology, ) was used instead of protein A Sepharose beads.
###end p 113
###begin title 114
Supporting Information
###end title 114
###begin title 115
Accession Numbers
###end title 115
###begin p 116
The Entrez Gene () accession numbers for gene products discussed in this paper are BAD (12015), BAX (12028), cadherin 1 (12550), myosin Va (17918), myosin, heavy polypeptide 9, non-muscle isoform 1 (17886), PDX1 (18609), snail homolog 1 (20613), and TVA (420066).
###end p 116
###begin p 117
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 1121 1127 1121 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-xL</italic>
###xml 1156 1164 1156 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-Bcl-xL;</italic>
###xml 1181 1190 1181 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-dnE-cad;</italic>
###xml 1237 1241 1237 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP;</italic>
###xml 227 232 <span type="species:ncbi:10090">Mouse</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 571 576 <span type="species:ncbi:10090">mouse</span>
###xml 1115 1120 <span type="species:ncbi:9606">human</span>
We thank Adam Olshen (Department of Epidemiology-Biostatistics, Memorial Sloan-Kettering Cancer Center [MSKCC]) for his generous help with applications of the Wilcoxon rank sum test and Kruskal-Wallis nonparametric test; MSKCC Mouse Genetics Core Facility for the generation of RIP-tva mice and foster service; Jennifer Demers, Anthony Daniyan, Mary Ann Melnick, Andreas Giannakou, and Daisy Chen for excellent technical assistance; other members of the Varmus laboratory, especially Katrina Podsypanina and Martin Jechlinger, for insightful discussions; Danny Huang for mouse database design; Hediye Erdjument-Bromage and the MSKCC Microchemistry & Proteomics Core Facilities for protein identification; William Pao, David Klimstra, Oriol Casanovas, Matthew Chun, Johanna Joyce, Satoru Kuwajima, Douglas Melton, Yuval Dor, Juliana Brown, Alan Hall, Aron Jaffe, and Irina Linkov for suggestions and protocols; Suzanne Ortiz, William Pao, Pang-Dian Fan, and Matthew Chun for critical reading of the manuscript; Andrew Leavitt for the anti-TVA antibody; Chris Wright for the anti-PDX1 antibody; Stanley Korsmeyer for human Bcl-xL cDNA; William Pao for RCASBP-Bcl-xL; Yi Li for RCASBP-dnE-cad; Maureen Peters and Constance Cepko for RCASBP-GFP; MSKCC Research Animal Resource Center for animal husbandry; and MSKCC Genomics, Molecular Cytology, and Flow Cytometry Core Facilities for technical assistance.
###end p 117
###begin title 118
Abbreviations
###end title 118
###begin p 119
###xml 0 5 <span type="species:ncbi:9606">human</span>
human placental alkaline phosphatase
###end p 119
###begin p 120
Dulbecco's Modified Eagle Medium
###end p 120
###begin p 121
a dominant-negative form of cadherin 1
###end p 121
###begin p 122
filamentous actin
###end p 122
###begin p 123
fluorescence-activated cell sorting
###end p 123
###begin p 124
###xml 6 12 <span type="species:ncbi:9913">bovine</span>
fetal bovine serum
###end p 124
###begin p 125
green fluorescent protein
###end p 125
###begin p 126
guanosine triphosphatase
###end p 126
###begin p 127
invasive carcinoma type 1
###end p 127
###begin p 128
invasive carcinoma type 2
###end p 128
###begin p 129
insulin-like growth factor
###end p 129
###begin p 130
immunoprecipitation
###end p 130
###begin p 131
noninvasive islet tumor
###end p 131
###begin p 132
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 33 53 <span type="species:ncbi:11864">avian leukosis virus</span>
###xml 91 94 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
subgroup A replication-competent avian leukosis virus with a splice acceptor and the Bryan-RSV pol gene
###end p 132
###begin p 133
###xml 0 3 <span type="species:ncbi:10116">rat</span>
rat insulin promoter
###end p 133
###begin p 134
sodium dodecyl sulfate polyacrylamide gel electrophoresis
###end p 134
###begin title 135
References
###end title 135
###begin article-title 136
The multistep nature of cancer
###end article-title 136
###begin article-title 137
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
###end article-title 137
###begin article-title 138
###xml 34 39 <span type="species:ncbi:9606">human</span>
The consensus coding sequences of human breast and colorectal cancers
###end article-title 138
###begin article-title 139
The hallmarks of cancer
###end article-title 139
###begin article-title 140
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
Conditional mouse models of sporadic cancer
###end article-title 140
###begin article-title 141
Cancer modeling in the modern era: Progress and challenges
###end article-title 141
###begin article-title 142
Conditional animal models: A strategy to define when oncogenes will be effective targets to treat cancer
###end article-title 142
###begin article-title 143
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Inducible gene targeting in mice using the Cre/lox system
###end article-title 143
###begin article-title 144
###xml 26 44 <span type="species:ncbi:11886">Rous sarcoma virus</span>
A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
###end article-title 144
###begin article-title 145
###xml 15 22 <span type="species:ncbi:9031">chicken</span>
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses
###end article-title 145
###begin article-title 146
###xml 55 70 <span type="species:ncbi:10090">transgenic mice</span>
###xml 102 117 <span type="species:ncbi:10633">simian virus 40</span>
Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
###end article-title 146
###begin article-title 147
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis
###end article-title 147
###begin article-title 148
###xml 78 84 <span type="species:ncbi:10090">murine</span>
Development of a flexible and specific gene delivery system for production of murine tumor models
###end article-title 148
###begin article-title 149
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
An RCAS-TVA-based approach to designer mouse models
###end article-title 149
###begin article-title 150
Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors
###end article-title 150
###begin article-title 151
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas
###end article-title 151
###begin article-title 152
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas
###end article-title 152
###begin article-title 153
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Demonstration of expanding cell populations in mouse pancreatic acini and islets
###end article-title 153
###begin article-title 154
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta
###end article-title 154
###begin article-title 155
Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation
###end article-title 155
###begin article-title 156
Cadherins regulate aggregation of pancreatic beta-cells in vivo
###end article-title 156
###begin article-title 157
A causal role for E-cadherin in the transition from adenoma to carcinoma
###end article-title 157
###begin article-title 158
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis
###end article-title 158
###begin article-title 159
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
###end article-title 159
###begin article-title 160
The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors
###end article-title 160
###begin article-title 161
Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression
###end article-title 161
###begin article-title 162
Tumour-cell invasion and migration: Diversity and escape mechanisms
###end article-title 162
###begin article-title 163
Cell migration: Integrating signals from front to back
###end article-title 163
###begin article-title 164
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells
###end article-title 164
###begin article-title 165
The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
###end article-title 165
###begin article-title 166
N-linked oligosaccharides are not involved in the function of a cell-cell binding glycoprotein E-cadherin
###end article-title 166
###begin article-title 167
Rho GTPases and the actin cytoskeleton
###end article-title 167
###begin article-title 168
###xml 53 59 <span type="species:ncbi:10090">murine</span>
bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria
###end article-title 168
###begin article-title 169
Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers
###end article-title 169
###begin article-title 170
Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
###end article-title 170
###begin article-title 171
The Bcl-2 apoptotic switch in cancer development and therapy
###end article-title 171
###begin article-title 172
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
###end article-title 172
###begin article-title 173
Unconventional myosins in cell movement, membrane traffic, and signal transduction
###end article-title 173
###begin article-title 174
Myosins: A diverse superfamily
###end article-title 174
###begin article-title 175
Regulation of protrusion, adhesion dynamics, and polarity by myosins IIA and IIB in migrating cells
###end article-title 175
###begin article-title 176
TGF-beta signaling in tumor suppression and cancer progression
###end article-title 176
###begin article-title 177
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer
###end article-title 177
###begin article-title 178
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
###end article-title 178
###begin article-title 179
Function of myosin-V in filopodial extension of neuronal growth cones
###end article-title 179
###begin article-title 180
A Dictyostelium myosin I plays a crucial role in regulating the frequency of pseudopods formed on the substratum
###end article-title 180
###begin article-title 181
Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness
###end article-title 181
###begin article-title 182
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma
###end article-title 182
###begin article-title 183
Bcl-2 initiates a new category of oncogenes: Regulators of cell death
###end article-title 183
###begin article-title 184
BCL-2 family: Regulators of cell death
###end article-title 184
###begin article-title 185
Bcl-XL and Bcl-2 repress a common pathway of cell death
###end article-title 185
###begin article-title 186
Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases
###end article-title 186
###begin article-title 187
###xml 28 33 <span type="species:ncbi:9606">human</span>
Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis
###end article-title 187
###begin article-title 188
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer
###end article-title 188
###begin article-title 189
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene
###end article-title 189
###begin article-title 190
###xml 143 148 <span type="species:ncbi:9031">chick</span>
Replication-competent retroviral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo
###end article-title 190
###begin article-title 191
###xml 9 16 <span type="species:ncbi:9031">chicken</span>
###xml 126 148 <span type="species:ncbi:11864">avian leukosis viruses</span>
The DF-1 chicken fibroblast cell line: Transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses
###end article-title 191
###begin article-title 192
The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors
###end article-title 192
###begin article-title 193
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
###end article-title 193
###begin article-title 194
Yph1p, an ORC-interacting protein: Potential links between cell proliferation control, DNA replication, and ribosome biogenesis
###end article-title 194
###begin article-title 195
Spatiotemporal expression of catenins, ZO-1, and occludin during early polarization of hepatic WIF-B9 cells
###end article-title 195
###begin p 196
currency Current address: University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
###end p 196
###begin p 197
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-tva</italic>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP-Tag</italic>
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
###xml 198 213 <span type="species:ncbi:10090">transgenic mice</span>
Author contributions. YND and HV designed the experiments. BCL generated RIP-tva transgenic mice and contributed to the general strategy. DH contributed to the general strategy and provided RIP-Tag transgenic mice, protocols, and advice. YND performed the research. YND wrote the paper with assistance from HV, and BCL and DH reviewed and helped to edit the paper.
###end p 197
###begin p 198
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported in part by PO1 CA94060 and funds from the W. M. Keck Foundation to HV. BCL received support from a Career Development Award in the Biomedical Sciences from the Burroughs Wellcome Fund.
###end p 198
###begin p 199
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 199

